Elite Health Systems Inc.
USNU
$1.10
-$0.10-8.33%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.56% | 27.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.56% | 27.65% | |||
| Operating Income | 13.56% | -27.65% | |||
| Income Before Tax | 58.47% | -252.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.47% | -252.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.47% | -252.07% | |||
| EBIT | 13.56% | -27.65% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 53.90% | -154.97% | |||
| Normalized Basic EPS | 53.68% | -154.21% | |||
| EPS Diluted | 53.90% | -154.97% | |||
| Normalized Diluted EPS | 53.68% | -154.21% | |||
| Average Basic Shares Outstanding | -10.03% | 37.79% | |||
| Average Diluted Shares Outstanding | -10.03% | 37.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||